In summary, our work aims at improving the understanding of the role of Ikaros/SHIP1 regulation and AKT isoforms in ALL, which could form the basis of a new targeted intervention of ALL in the future. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.